Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.

Jupiter Endovascular completes enrollment in a pivotal trial of its Vertex system with Transforming Fixation technology for pulmonary embolectomy.

Pulmonary embolism (PE) remains a major cause of cardiovascular morbidity and mortality worldwide. It occurs when thrombotic material—most often ...

“In these first cases, the Vertex system was successful in safely navigating through the right heart and into the pulmonary vasculature, facilitating an efficient and effective pulmonary embolectomy ...

LMH Health is adding innovative procedures that could make a big difference for cardiac patients in our community. From the ...

Pulmonary embolism (PE) is a common and potentially life-threatening condition with presentations ranging from mild symptoms to circulatory collapse. Early and accurate risk stratification is ...

Approximately one in six patients hospitalized for a first episode of syncope have a pulmonary embolism, a new study shows, with the prevalence of pulmonary embolism highest among individuals without ...

THE rationale for venous ligation in pulmonary embolic disease is based on its assumed ability to prevent subsequent emboli from reaching the lungs. The level of the inferior vena cava is now ...

THE diagnosis of massive pulmonary embolism is frequently difficult and always uncertain, primarily because the symptoms and signs may mimic those of some other diseases, such as myocardial infarction ...